Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.
about
Biomarkers and biometric measures of adherence to use of ARV-based vaginal ringsThe complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathwayA phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGelĀ®) in healthy young women administered twice daily for 14 daysBiological factors that may contribute to regional and racial disparities in HIV prevalence.Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract.Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture.Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili studySemen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIVStability and transport of cervical cytobrushes for isolation of mononuclear cells from the female genital tractReduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies.Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding.Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tractPlasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safetySchistosoma mansoni Infection in Ugandan Men Is Associated with Increased Abundance and Function of HIV Target Cells in Blood, but Not the Foreskin: A Cross-sectional Study.Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.Cryopreservation of Human Mucosal Leukocytes.Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidalInteraction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan womenA study of the osmotic characteristics, water permeability, and cryoprotectant permeability of human vaginal immune cellsHave the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?Rapid acquisition of HPV around the time of sexual debut in adolescent girls in TanzaniaEvaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.Methodological issues in sampling the local immune system of the female genital tract in the context of HIV prevention trials.Coming of age: reconstruction of heterosexual HIV-1 transmission in human ex vivo organ culture systems.Inflammation and HIV Transmission in Sub-Saharan Africa.Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships.Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.The wrong place at the wrong time: geographic disparities in young people's HIV RiskMarked differences in CCR5 expression and activation levels in two South African populations.TNF-alpha modulates adipose macrophage polarization to M1 phenotype in response to scorpion venom.
P2860
Q26753097-F6D7C42A-7995-4272-A929-4CF3033D8839Q27692596-C9E44344-C57B-4359-846B-E2F114767A1DQ28728928-6B783F31-6272-468C-9FB8-21F179EF04B7Q28743383-503F02C4-217A-4C6B-A694-22F3571A69B1Q30398456-A1A3E65D-70B2-46D3-9ACA-96090F1A4928Q33711969-31057F0F-B9F4-4915-A9FA-04D8991F3515Q33983315-D080BAAD-B02A-4774-ABA7-9FE4CF71939AQ34240204-13BDEA57-1395-4FDA-943D-9A3568EA955FQ34767047-958D0620-44B3-45DA-A10E-42BE8578A47CQ34837115-E6C94F28-953E-43A9-AEC8-F146D20F6B18Q35174468-C9056449-F57B-40A1-BE01-5D7246985843Q35256845-C33487FA-1D68-487F-AD15-9EDA9A103871Q35331430-A5E9C58D-69D6-4F22-AF3E-6A15E43B5066Q35636288-DA7E1E73-F7C2-4D36-9413-4A09A33605C7Q35661895-9FDCE2B4-F13A-44D9-91F2-4504CE82E731Q35681023-9C13FF54-29C7-4F9A-A230-2BBD6BB4DD1FQ35763313-FC48D787-C17A-4EB3-A2E9-3FC55AB36FA9Q35774494-4C8857B0-4D6B-472C-991A-D3197DEBE01BQ36032572-1ADCF70C-C6BE-46BB-8142-F2328886F3D3Q36068904-6CB3CFAB-9D2F-437E-AF28-A4CB68958D76Q36092095-0A54F554-ACF1-4E30-B2C1-789E877E091AQ36509620-4840F6D0-4FF3-48E5-8C70-83BF3C490B69Q36545289-A05980B3-A3B7-44AF-BF2B-8861701024CBQ36791785-400742BF-392B-404E-A315-9B0B219E4E78Q37050010-A4A0890B-31B3-40DE-BC09-F8BE59FB2CA8Q37219765-47630058-FC87-4C67-B51E-8AD1B7B08FDBQ37544670-9E0EE697-1F97-4DC6-B146-D9C687721528Q37825568-572B67D7-26B2-4B30-975A-80855185B3A2Q37856708-D5BBE5BA-72F4-4369-9E44-C66960953EF7Q38422546-5F05CBE1-B484-4DB6-913D-9D0C92584523Q38968366-04CC98E6-698A-4924-A13A-7C17D3E443D0Q40248163-020C67E2-5391-4485-A20D-F3722DBE124DQ41928445-A7E3D191-379A-417D-BCCC-26DF46A88FE0Q42763795-82C93DB7-D40C-4133-92A7-1FF1A987A9F9Q45015137-55EB923A-753A-487B-AFB6-2B67F5AF66A1Q53333538-81538F07-932E-4838-B861-6ED1E9EB4A4C
P2860
Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.
description
2010 nĆ® lÅ«n-bĆ»n
@nan
2010 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ£ÕøÕ½ÕæÕøÕ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2010 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Ö
Õ£ÕøÕ½ÕæÕøÕ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2010幓ć®č«ę
@ja
2010幓č«ę
@yue
2010幓č«ę
@zh-hant
2010幓č«ę
@zh-hk
2010幓č«ę
@zh-mo
2010幓č«ę
@zh-tw
2010幓č®ŗę
@wuu
name
Increased levels of immune act ...... women from sub-Saharan Africa.
@ast
Increased levels of immune act ...... women from sub-Saharan Africa.
@en
Increased levels of immune act ...... women from sub-Saharan Africa.
@nl
type
label
Increased levels of immune act ...... women from sub-Saharan Africa.
@ast
Increased levels of immune act ...... women from sub-Saharan Africa.
@en
Increased levels of immune act ...... women from sub-Saharan Africa.
@nl
prefLabel
Increased levels of immune act ...... women from sub-Saharan Africa.
@ast
Increased levels of immune act ...... women from sub-Saharan Africa.
@en
Increased levels of immune act ...... women from sub-Saharan Africa.
@nl
P2093
P2860
P50
P1433
P1476
Increased levels of immune act ...... women from sub-Saharan Africa.
@en
P2093
Anna-Barbara Moscicki
Anu Rebbapragada
Ibrahim Daud
Joelle Brown
Mark E Scott
Stephen Shiboski
P2860
P304
P356
10.1097/QAD.0B013E32833C323B
P407
P577
2010-08-01T00:00:00Z